EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcification

Nikolaos T Skenteris, Esmeralda Hemme, Lucie Delfos, Glykeria Karadimou, Eva Karlöf, Mariette Lengquist, Malin Kronqvist, Xiang Zhang, Lars Maegdefessel, Leon J Schurgers, Hildur Arnardottir, Erik A L Biessen und 2 weitere

Vascular Pharmacology · 2023

DOI: 10.1016/j.vph.2023.107167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular Pharmacology, 2023. Verfasst von Nikolaos T Skenteris und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden; Vascular Surgery, Department of Molecular Medicine and Surg…. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Carotid Stenosis, Atherosclerosis, Vascular Calcification. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hjärt-Lungfonden, Henry Luce Foundation, Karolinska Institutet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Calcification, a key feature of advanced human atherosclerosis, is positively associated with vascular disease burden and adverse events. We showed that macrocalcification can be a stabilizing factor for carotid plaque molecular biology, due to inverse association with immune processes. Mast cells (MCs) are important contributors to plaque instability, but their relationship with macrocalcification is unexplored. With a hypothesis that MC activation negatively associates with carotid plaque macrocalcification, we aimed to investigate the link between MCs and carotid plaque vulnerability, and study MC role in plaque calcification via smooth muscle cells (SMCs). METHODS: Pre-operative computed tomography angiographies of patients (n = 40) undergoing surgery for carotid stenosis were used to characterize plaque morphology. Plaque microarrays (n = 40 and n = 126) were used for bioinformatic deconvolution of immune cell populations. Tissue microarrays (n = 103) were used to histologically validate the contribution of activated and resting MCs in plaques. RESULTS: Activated MCs and their typical markers were negatively correlated with macrocalcification. The ratio of activated vs. resting MCs was increased in low-calcified plaques from symptomatic patients. There was no modulating effect of medication on MC ratios. In vitro experiments showed that SMC calcification attenuated MC activation, while both active and resting MCs stimulated SMC calcification and induced dedifferentiation towards a pro-inflammatory-, osteochondrocyte-like phenotype, without modulating their migro-proliferative function. CONCLUSIONS: Integrative analyses from human plaques showed that MC activation is inversely associated with macrocalcification and positively with parameters of plaque vulnerability. Mechanistically, MCs induce SMC osteogenic reprograming, while matrix calcification in turn attenuates MC activation, offering new therapeutic avenues for exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AtheroscleroticCarotid StenosisAtherosclerosisVascular CalcificationHumansMast CellsMyocytes, Smooth Muscle

Stichwörter der Autor:innen

Atherosclerotic plaquesBiobank of Karolinska endarterectomy (BiKE)Intimal calcificationMast cellsSmooth muscle cells

Autor:innen und Institutionen

  • Cardiovascular Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden; Vascular Surgery, Department of Molecular Medicine and Surgery, Karolinska Institute and Karolinska University Hospital, Stockhol…
  • Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.
  • Vascular Surgery, Department of Molecular Medicine and Surgery, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
  • Cardiovascular Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden; Technical University Munich, Klinikum rechts der Isar, Department for Vascular and Endovascular Surgery, Germany.
  • Department of Biochemistry and CARIM, School for Cardiovascular Diseases, Maastricht University, The Netherlands; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Cardiovascular Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden.

Förderung

  • Hjärt-Lungfonden
  • Henry Luce Foundation
  • Karolinska Institutet
  • H2020 Marie Skłodowska-Curie Actions
  • Vetenskapsrådet
  • European Union's Research and Innovation
  • Horizon 2020
  • Hartstichting

Zitieren

APA

Skenteris, N. T., Hemme, E., Delfos, L., Karadimou, G., Karlöf, E., Lengquist, M., Kronqvist, M., Zhang, X., Maegdefessel, L., Schurgers, L. J., Arnardottir, H., Biessen, E. A. L., Bot, I., & Matic, L. (2023). Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcification. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2023.107167

Vancouver

Skenteris NT, Hemme E, Delfos L, Karadimou G, Karlöf E, Lengquist M, et al. Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcification. Vascular Pharmacology. 2023. doi:10.1016/j.vph.2023.107167

BibTeX
@article{Skenteris2023,
  author = {Skenteris, Nikolaos T and Hemme, Esmeralda and Delfos, Lucie and Karadimou, Glykeria and Karlöf, Eva and Lengquist, Mariette and Kronqvist, Malin and Zhang, Xiang and Maegdefessel, Lars and Schurgers, Leon J and Arnardottir, Hildur and Biessen, Erik A L and Bot, Ilze and Matic, Ljubica},
  title = {Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcification},
  journal = {Vascular Pharmacology},
  year = {2023},
  doi = {10.1016/j.vph.2023.107167}
}
Kostenlos starten →